Description
MOD TO EXTEND SERVICES POP 04/01/2022 TO 09/30/2022
Base award description: CHEMISTRY&IMMUNOASSAY CPRR - VISN 21
Modification chain · 13 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-03-28+$295,579= $295,579
- Mod P000012017-10-01+$591,158= $886,737
- Mod P000022018-10-01+$591,158= $1,477,896
- Mod P000032018-12-12+$10,710= $1,488,606
- Mod P000042019-08-05-$27,633= $1,460,973
- Mod P000052019-10-01+$591,158= $2,052,131
- Mod P000062020-04-07-$23,467= $2,028,664
- Mod P000072020-10-01+$591,158= $2,619,823
- Mod P000082021-01-31-$219,780= $2,400,043
- Mod P000092021-10-01+$295,579= $2,695,622
- Mod P000102022-02-08+$240,000= $2,935,622
- Mod P000112022-05-20-$163,058= $2,772,564
- Mod P000122023-06-30-$94,556= $2,678,008
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-03-28 | +$295,579 | $295,579 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00001· EXERCISE AN OPTION | 2017-10-01 | +$591,158 | $886,737 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00002· EXERCISE AN OPTION | 2018-10-01 | +$591,158 | $1,477,896 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00003· FUNDING ONLY ACTION | 2018-12-12 | +$10,710 | $1,488,606 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00004· ADDITIONAL WORK (NEW AGREEMENT,FAR PART 6 APPLIES) | 2019-08-05 | −$27,633 | $1,460,973 | DEOBLIGATION AND CLOSE OUT OF BASE YEAR |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-10-01 | +$591,158 | $2,052,131 | OPTION YEAR FOR LAB EQUIPMENT |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-04-07 | −$23,467 | $2,028,664 | MOD TO DECREASE EXCESS FUNDS FOR OY#2 |
| Mod P00007· EXERCISE AN OPTION | 2020-10-01 | +$591,158 | $2,619,823 | MOD TO DECREASE EXCESS FUNDS FOR OY#2 |
| Mod P00008· FUNDING ONLY ACTION | 2021-01-31 | −$219,780 | $2,400,043 | MOD TO DECREASE EXCESS FUNDS FOR OY#2 |
| Mod P00009· EXERCISE AN OPTION | 2021-10-01 | +$295,579 | $2,695,622 | MOD TO EXERCISE OPTION 5 - POP 10/01/2021 TO 03/31/2022 |
| Mod P00010· EXERCISE AN OPTION | 2022-02-08 | +$240,000 | $2,935,622 | MOD TO EXTEND SERVICES POP 04/01/2022 TO 09/30/2022 |
| Mod P00011· FUNDING ONLY ACTION | 2022-05-20 | −$163,058 | $2,772,564 | MOD TO EXTEND SERVICES POP 04/01/2022 TO 09/30/2022 |
| Mod P00012· FUNDING ONLY ACTION | 2023-06-30 | −$94,556 | $2,678,008 | MOD TO EXTEND SERVICES POP 04/01/2022 TO 09/30/2022 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PU6HHX2R11C7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0869 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $111,853 | FY2026 |
| 36C25726N0476 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,450,556 | FY2026 |
| 36C25926N0424 | NETWORK CONTRACT OFFICE 19 (36C259) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $2,989,154 | FY2026 |
| 36C25726N0456 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $365,580 | FY2026 |
| 36C24426N0923 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $84,816 | FY2026 |
| 36C24426N0922 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $46,600 | FY2026 |
Other recipients under 6630 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126F0309 | BIOMERIEUX INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $360,089 | FY2026 |
| 36C26126N0375 | BIOMERIEUX INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $136,706 | FY2026 |
| 36C26126N0135 | POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $37,831 | FY2026 |
| 36C26126F0020 | BIOMERIEUX INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $278,149 | FY2026 |
| 36C26126N0078 | ORTHO-CLINICAL DIAGNOSTICS, INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $154,375 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26117F1588_3600_V797P7090A_3600 · retrieved 2026-09-26.